Uniswap customer support, Uniswap customer care Uniswap customer care number Uniswap customer service Uniswap support,

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

4D Pharma Research Ltd., a subsidiary of 4D Pharma Plc, is a British company located in Aberdeen that engages in research and experimental development on biotechnology.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Part of University of Aberdeen, The Rowett Research Institute is a British company located in Aberdeen that engages in conducting research to help in solving nutritional problems. It was founded in 1962.

National University Corp. Tokyo Medical & Dental University is a private company headquartered in Japan that operates as an national educational institution for dentistry.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Bioneer is a biotech company that develops molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation. From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer was established in 1992 and is based in Daejeon, South Korea.

Recombinetics is a developer of gene editing technologies to improve human health through advanced disease models and regenerative medicine. Its gene-editing technologies manipulate deoxyribonucleic acid (DNA) samples to add and activate genes to solve problems and also offer gene repair and gene editing tools that enable biomedical research, livestock productivity, animal agriculture, and livestock vertical markets to modify animal genomes accurately and efficiently.

Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The company’s research and development activities focus on infectious diseases and cardiometabolic disorders, while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, cardiovascular disease, infectious and inflammatory diseases, and rare genetic disorders. The company has strategic partnerships with miRagen Therapeutics, Shire PLC, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. As part of its broad patent estate, the company holds exclusive worldwide rights to manufacture, have manufactured and sell products that contain LNA as an active ingredient for studies performed with a view to obtaining marketing approval. Santaris Pharma A/S, founded in 2003, is headquartered in Denmark with operations in the United States.

RiboGene is a drug discovery company focused on the identification of novel leads and the development of potential drug candidates for the treatment of infectious diseases. The Company's drug discovery efforts target bacterial, fungal and viral infections for which the efficacy of existing therapies is being threatened by the emergence of drug resistance or for which existing therapies have had limited effectiveness. The Company's drug discovery technology is based on the translational control of gene expression.

Hunan Laituofu Biotechnology Co., Ltd., established on 2011-12-26, Business scope includes biological reagents,Class I medical device,Class II medical device,Class III Medical Devices,Chemical Reagents and Auxiliaries(Monitor Chemicals,Excluding hazardous chemicals),Class II:6840In vitro diagnostic reagent development;Chemical Reagent and Auxiliary Manufacturing;Class I medical device,Class II medical device,Class III Medical Devices,Class II:6840Production of in vitro diagnostic reagents;Class I medical device,Class II medical device,Class III Medical Devices,biological reagent,Chemical Reagents and Auxiliaries(Monitor Chemicals,Excluding hazardous chemicals),Class II:6840Sales of in vitro diagnostic reagents;Medical device technology promotion service;Biotechnology Extension Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Novapure Corp, a subsidiary of Advanced Materials Group, Inc., is an American company focused on general industrial machinery and equipment. On September 29, 1994 Advanced Materials Group, Inc. acquired Novapure Corp from EMD Millipore Corp.

TCI Co., Ltd. engages in the research, development, manufacturing, and sales of health foods and care products. The firm's products include function drinks for beauty, slim, health and energy, function foods in double-layered tablets, capsules, microencapsulated beads and sachet, cosmetics and care products, including creams, bio-cellulose masks, sprays and mousses, and dietary supplements. It operates through the following geographical segments: Taiwan, Asia, and Other. The company was founded on August 22, 1980 and is headquartered in Taipei, Taiwan.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.